How Science and Strategic Collaboration Led to a New, “Personalized” Cystic Fibrosis Treatment for Some Patients
Updated: 2012-01-31 21:21:45
written by Janet Woodcock, MD, Director for FDA’s Center for Drug Evaluation and Research
Targeting a drug for small subgroups of patients is a new way to find effective therapies. This is often called personalized medicine, and it’s one of today’s most promising areas of new drug development. Last year, FDA ...